Novartis
NVS
#55
Rank
NZ$440.64 B
Marketcap
NZ$229.65
Share price
-0.96%
Change (1 day)
36.99%
Change (1 year)

Novartis AG is a biotechnology and pharmaceutical company based in Basel, Switzerland. Novartis was formed in 1996 from a merger of the two Basel pharmaceutical and chemical companies Ciba-Geigy AG and Sandoz AG. Novartis is one of the largest pharmaceutical companies in the world with sales of USD 47.4 billion in 2019.

EPS for Novartis (NVS)

EPS in 2025 (TTM): NZ$12.66

According to Novartis's latest financial reports the company's current EPS (TTM) is NZ$12.76. In 2024 the company made an earnings per share (EPS) of NZ$10.25.

EPS history for Novartis from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$12.6623.55%
2024NZ$10.25
2022NZ$5.53-70.24%
2021NZ$18.59201.97%
2020NZ$6.16-30.53%
2019NZ$8.86
2017NZ$5.6916.31%
2016NZ$4.89-61.84%
2015NZ$12.8175.53%
2014NZ$7.3012.27%
2013NZ$6.50-2.6%
2012NZ$6.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merck
MRK
NZ$13.17 3.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.98-76.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$18.10 41.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$6.43-49.65%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$6.24-51.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$1.09-91.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bristol-Myers Squibb
BMY
NZ$5.15-59.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.97 9.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$5.26-58.76%๐Ÿ‡ฌ๐Ÿ‡ง UK